STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
IRMD IRADIMED CORPORATION StockScouter® Report
2
StockScouter® Score
IRADIMED CORPORATION, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Shares are under accumulation by financial institutions. Marginally positive for a small company like IRMD
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
- The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
D
C
F
D